Literature DB >> 12527825

[Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy. Results of the first prospective pilot study].

M Mauget-Faÿsse1, L Kodjikian, M Quaranta, D Ben Ezra, C Trepsat, F Mion, F Mégraud.   

Abstract

PURPOSE: Helicobacter pylori has been implicated in focal occlusive arterial diseases in young people. Central serous chorioretinopathy (CSC) and diffuse retinal epitheliopathy (DRE) being suspected vascular occlusive diseases of choriocapillaris, the purpose of this study was to determine the prevalence of H. pylori infection in patients with long-lasting (>6 months) CSC and/or DRE.
METHODS: Sixteen consecutive patients living in southeastern France were included in this prospective pilot study. H. pylori infection was assessed by the (13)C-urea breath test, serology, as well as histology of gastric biopsy specimens in some cases.
RESULTS: Evidence for H. pylori infection was detected in nine out of the 16 patients with active long-lasting CSC/DRE (56.3%). H. pylori-infected patients more frequently presented gastric pain (four of nine H. pylori-positive patients: 44%) than H. pylori-negative patients (one out of seven: 14%). Men were more frequently H. pylori-positive (seven men out of ten: 70%) than women (two women out of a total of six: 33%). DISCUSSION: When the prevalence of H. pylori infection (56.3%) was compared to the prevalence in a historical control population from southeastern France (27.5%), it was found to be significantly higher (P<0.05).
CONCLUSION: These results may indicate a possible association between H. pylori infection and CSC/DRE manifestations. This new etiopathogenic hypothesis deserves to be confirmed in a national or international multicenter study because it could lead to a new therapeutic approach in CSC/DRE, i.e., Helicobacter pylori eradication.

Entities:  

Mesh:

Year:  2002        PMID: 12527825

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  14 in total

Review 1.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

2.  The association of Helicobacter pylori with choroidal and retinal nerve fiber layer thickness.

Authors:  Mehmet Erol Can; Fatma Efe Kaplan; Mehmet Murat Uzel; Hasan Kiziltoprak; Mustafa Cagri Ergun; Mustafa Koc; Gülcin Simsek
Journal:  Int Ophthalmol       Date:  2017-08-05       Impact factor: 2.031

Review 3.  Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review.

Authors:  Aránzazu Mateo-Montoya; Martine Mauget-Faÿse
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

4.  Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy.

Authors:  Olesya Zavoloka; Pavlo Bezditko; Irina Lahorzhevska; Darya Zubkova; Yevgeniya Ilyina
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-16       Impact factor: 3.117

Review 5.  Oral medications for central serous chorioretinopathy: a literature review.

Authors:  William Fusi-Rubiano; Habiba Saedon; Vijay Patel; Yit C Yang
Journal:  Eye (Lond)       Date:  2019-09-16       Impact factor: 3.775

Review 6.  Impact of Climate Change on Eye Diseases and Associated Economical Costs.

Authors:  Lucía Echevarría-Lucas; José Mᵃ Senciales-González; María Eloísa Medialdea-Hurtado; Jesús Rodrigo-Comino
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

7.  Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy.

Authors:  Antonio Marcelo Barbante Casella; Rodrigo Fabri Berbel; Gláucio Luciano Bressanim; Marcus Rudolph Malaguido; José Augusto Cardillo
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

8.  The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy.

Authors:  Mohammad Bagher Rahbani-Nobar; Alireza Javadzadeh; Leila Ghojazadeh; Mandana Rafeey; Amir Ghorbanihaghjo
Journal:  Mol Vis       Date:  2011-01-11       Impact factor: 2.367

9.  Association of Helicobacter pylori with central serous chorioretinopathy in Iranian patients.

Authors:  Mohammad Roshani; Nasrin Ahangar Davoodi; Mohammad Reza Seyyedmajidi; Homayoun Zojaji; Somayeh Jahani Sherafat; Massih Hashemi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

10.  The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients.

Authors:  Yalong Dang; Yalin Mu; Manli Zhao; Lin Li; Yaning Guo; Yu Zhu
Journal:  Ther Clin Risk Manag       Date:  2013-09-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.